Staar Surgical Co. (NASDAQ:STAA)’s share price traded down 2.1% on Thursday . The stock traded as low as $8.92 and last traded at $8.97, with a volume of 51,738 shares. The stock had previously closed at $9.16.

Several equities analysts recently weighed in on the company. Benchmark Co. raised Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 price objective for the company in a research report on Wednesday, May 18th. Stephens cut Staar Surgical from an “overweight” rating to an “equal weight” rating in a research report on Thursday, May 12th. Zacks Investment Research raised Staar Surgical from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 13th. Canaccord Genuity reissued a “hold” rating and set a $7.00 price objective on shares of Staar Surgical in a research report on Thursday, May 12th. Finally, William Blair reissued a “market perform” rating on shares of Staar Surgical in a research report on Thursday, August 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $7.50.

The company’s 50-day moving average is $7.17 and its 200-day moving average is $6.72. The stock’s market capitalization is $367.11 million.

Staar Surgical (NASDAQ:STAA) last released its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.05). The firm earned $21 million during the quarter, compared to analyst estimates of $19.88 million. Staar Surgical’s revenue for the quarter was up 12.4% on a year-over-year basis. Equities analysts expect that Staar Surgical Co. will post ($0.31) earnings per share for the current year.

In related news, major shareholder Broadwood Partners Lp acquired 70,000 shares of the firm’s stock in a transaction dated Tuesday, May 24th. The stock was bought at an average price of $5.16 per share, for a total transaction of $361,200.00. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC increased its stake in shares of Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned 0.54% of Staar Surgical worth $1,547,000 as of its most recent filing with the SEC.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.